Drug Type Biological products |
Synonyms HS 216, HS216 |
Target |
Mechanism Eph modulators(Ephrin receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioma | Preclinical | IT | 15 Apr 2022 |